The contemporary global context is characterized by a marked trend of population aging, with the prevalence of osteoporosis among individuals over the age of 50 in China exceeding 19.2%, and reaching 32% among those over 65. 4 In addition to lowering patients’ quality of life, bone metabolic diseases like osteoporosis and osteoarthritis place a heavy strain on families and society as a whole.
1
—
—